1996
DOI: 10.1177/106002809603001116
|View full text |Cite
|
Sign up to set email alerts
|

Prevention and Regression of Atherosclerosis: Effects of Hmg-CoA Reductase Inhibitors

Abstract: Aggressive lipid-lowering therapy using HMG-CoA reductase inhibitors appears to alter the natural progression and promote regression of atherosclerosis in selected patients with established coronary or carotid atherosclerosis. However, it is unlikely that regression of atherosclerosis alone is responsible for the marked reduction in clinical cardiac events seen in these trials.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1999
1999
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 44 publications
0
2
0
Order By: Relevance
“…This may be why an effect of lipid-lowering therapy on a lower incidence of MI 107,108 and stroke 109 -111 can be seen without a major change in plaque size or volume (ie, degree of stenosis). 104,106,112 Lowering of plasma and LDL cholesterol levels has been shown to lead to reduced progression or even regression of atherosclerotic disease in coronary, 113 femoral, 114 and carotid arteries (IMT) [115][116][117][118] and to reduced incidence of MI, 114 cerebrovascular events, 109 -111 and even death. 111 There are several reasons why lipid-lowering therapy has not shown a pronounced benefit to stroke patients until recently.…”
Section: Influence Of Plasma Cholesterol Lowering On Stroke Riskmentioning
confidence: 99%
“…This may be why an effect of lipid-lowering therapy on a lower incidence of MI 107,108 and stroke 109 -111 can be seen without a major change in plaque size or volume (ie, degree of stenosis). 104,106,112 Lowering of plasma and LDL cholesterol levels has been shown to lead to reduced progression or even regression of atherosclerotic disease in coronary, 113 femoral, 114 and carotid arteries (IMT) [115][116][117][118] and to reduced incidence of MI, 114 cerebrovascular events, 109 -111 and even death. 111 There are several reasons why lipid-lowering therapy has not shown a pronounced benefit to stroke patients until recently.…”
Section: Influence Of Plasma Cholesterol Lowering On Stroke Riskmentioning
confidence: 99%
“…Atherosclerosis is the most common type of occlusive cardiovascular disease (Schillinger et al, 2002, and Charo et al, 2011). Current therapies aimed at retarding atherosclerosis are centered on hypolipidemic, hypoglycemic and anti-hypertensive medications (Bjelajac et al, 1996). Nonetheless, when advanced plaques ultimately become occlusive or rupture, interventional procedures are required.…”
Section: Discussionmentioning
confidence: 99%